Difference in stroke outcomes by thrombolytic agent, route, or dose?

In patients with acute ischemic stroke, do different thrombolytic doses, agents, or routes of administration lead to different outcomes? Two of our editors – Adaira Landry and Alex Koyfman – address this question in a systematic review snapshot in the April 2014 issue of Annals. The fulltext is available here.

Leave a Reply

Your email address will not be published. Required fields are marked *